Cybin Inc (NY: CYBN )
0.2650
-0.0030
(-1.12%)
Streaming Delayed Price
Updated: 2:33 PM EDT, Aug 26, 2024
Add to My Watchlist
Press Releases about Cybin Inc
![](https://mms.businesswire.com/media/20230524005312/en/1801826/22/Cybin_Side_Logo.jpg)
From Cybin Inc.
Via Business Wire
![](https://mms.businesswire.com/media/20230509005435/en/1787255/22/Cybin_Side_Logo_%28004%29.jpg)
![](https://mms.businesswire.com/media/20230427005807/en/1776977/22/Cybin_Side_Logo.jpg)
From Cybin Inc.
Via Business Wire
![](https://mms.businesswire.com/media/20230412005176/en/1761253/22/Cybin_Side_Logo_%28004%29.jpg)
![](https://mms.businesswire.com/media/20230308005203/en/1732849/22/Cybin_Side_Logo_%28004%29.jpg)
From Cybin Inc.
Via Business Wire
![](https://www.businesswire.com/images/bwlogo_extreme.png)
![](https://mms.businesswire.com/media/20230228005438/en/1724443/22/Cybin_Side_Logo_%28004%29.jpg)
![](https://mms.businesswire.com/media/20230222006011/en/1720701/22/Cybin_Side_Logo_%28004%29.jpg)
![](https://mms.businesswire.com/media/20230214005365/en/1712809/22/Cybin_Side_Logo_%28004%29.jpg)
From Cybin Inc.
Via Business Wire
![](https://mms.businesswire.com/media/20230201005381/en/1702140/22/Cybin_Side_Logo_%28004%29.jpg)
Cybin Announces Approval of First-in-Human Dosing of its Proprietary DMT Molecule CYB004
February 01, 2023
From Cybin Inc.
Via Business Wire
Psychedelic-Derived Medicines for Neurologic Conditions Fueling Large Revenue Growth in Projected $4 Billion Dollar Industry
January 26, 2023
Topics
Economy
Exposures
Supply Chain
![](https://mms.businesswire.com/media/20230126005396/en/1696867/22/Cybin_Side_Logo_%28004%29.jpg)
Cybin to Host Virtual R&D Day on February 28, 2023
January 26, 2023
From Cybin Inc.
Via Business Wire
![](https://mms.businesswire.com/media/20230118005355/en/1688896/22/Cybin_Side_Logo_%28004%29.jpg)
![](https://mms.businesswire.com/media/20230112005249/en/1684085/22/Cybin_Side_Logo_%28004%29.jpg)
![](https://mms.businesswire.com/media/20230108005044/en/1679914/22/Cybin_Side_Logo_%28004%29.jpg)
Cybin Outlines Upcoming Priorities and Milestones for its Clinical Development Programs
January 08, 2023
From Cybin Inc.
Via Business Wire
![](https://mms.businesswire.com/media/20221220005245/en/1669343/22/Cybin_Side_Logo.jpg)
Cybin Highlights 2022 Accomplishments and Milestones
December 20, 2022
From Cybin Inc.
Via Business Wire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.